Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
sell

Intellia Therapeutics Inc sell StockNews.com

Intellia Therapeutics Inc
Start price
€7.98
27.12.25 / 50%
Target price
-
27.12.26
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 27.12.26. The prediction end date can be changed by StockNews_com at any time.
Performance without dividends (%)
Name 1w
Intellia Therapeutics Inc -
iShares Core DAX® 0.224%
iShares Nasdaq 100 0.371%
iShares Nikkei 225® 0.972%
iShares S&P 500 0.417%

Comments by StockNews_com for this prediction

In the thread Intellia Therapeutics Inc diskutieren

Intellia Therapeutics (NASDAQ:NTLA) was downgraded by analysts at Wall Street Zen from a "hold" rating to a "sell" rating.
Ratings data for NTLA provided by MarketBeat

StockNews.com 
0
Report Share
27.12.25 Sell -

Stopped prediction by StockNews_com for Intellia Therapeutics Inc

sell
Intellia Therapeutics Inc

Start price
Target price
Perf. (%)
€7.77
30.11.25
-
30.11.26
2.70%
23.12.25

StockNews.com 
30.11.25 50%
sell
Intellia Therapeutics Inc

Start price
Target price
Perf. (%)
€9.06
08.11.25
-
08.11.26
-11.90%
23.12.25

StockNews.com 
08.11.25 50%
sell
Intellia Therapeutics Inc

Start price
Target price
Perf. (%)
€15.77
09.11.24
-
09.11.25
-42.57%
10.11.25

StockNews.com 
09.11.24 50%
sell
Intellia Therapeutics Inc

Start price
Target price
Perf. (%)
€22.51
11.05.24
-
11.05.25
-67.08%
12.05.25

StockNews.com 
11.05.24 50%